171 related articles for article (PubMed ID: 2438645)
1. [Interferons in hemato-cancerology].
Boiron M
Nouv Rev Fr Hematol (1978); 1987; 29(1):49-55. PubMed ID: 2438645
[TBL] [Abstract][Full Text] [Related]
2. Future developments in interferon therapy.
Boiron M
Int J Cancer Suppl; 1987; 1():41-4. PubMed ID: 2442113
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of angiogenesis by interferons: effects on tumor- and lymphocyte-induced vascular responses.
Sidky YA; Borden EC
Cancer Res; 1987 Oct; 47(19):5155-61. PubMed ID: 2441862
[TBL] [Abstract][Full Text] [Related]
4. Role of biological response modifiers in immunochemotherapy of solid tumors and retroviral-induced leukemia.
Fuggetta MP; D'Onofrio C; Bonmassar E
Ann Ist Super Sanita; 1990; 26(3-4):385-95. PubMed ID: 1708953
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of interferon action in hairy cell leukemia: a model of effective cancer biotherapy.
Vedantham S; Gamliel H; Golomb HM
Cancer Res; 1992 Mar; 52(5):1056-66. PubMed ID: 1737364
[TBL] [Abstract][Full Text] [Related]
6. [Interferons, a class of cytokines with a large therapeutic activity range].
Billard C
Bull Cancer; 1993 Sep; 80(9):741-56. PubMed ID: 7515733
[TBL] [Abstract][Full Text] [Related]
7. Prolactin activates Stat1 but does not antagonize Stat1 activation and growth inhibition by type I interferons in human breast cancer cells.
Schaber JD; Fang H; Xu J; Grimley PM; Rui H
Cancer Res; 1998 May; 58(9):1914-9. PubMed ID: 9581833
[TBL] [Abstract][Full Text] [Related]
8. Interferon-gamma: biologic functions and HCV therapy (type I/II) (1 of 2 parts).
Gattoni A; Parlato A; Vangieri B; Bresciani M; Derna R
Clin Ter; 2006; 157(4):377-86. PubMed ID: 17051976
[TBL] [Abstract][Full Text] [Related]
9. Regulation of C1-inhibitor synthesis by interferons and other agents.
Lappin D; Whaley K
Behring Inst Mitt; 1989 Jul; (84):180-92. PubMed ID: 2478116
[TBL] [Abstract][Full Text] [Related]
10. Potentiation of radiation cytotoxicity by recombinant interferons, a phenomenon associated with increased blockage at the G2-M phase of the cell cycle.
Chang AY; Keng PC
Cancer Res; 1987 Aug; 47(16):4338-41. PubMed ID: 2440565
[TBL] [Abstract][Full Text] [Related]
11. IFI 16 gene encodes a nuclear protein whose expression is induced by interferons in human myeloid leukaemia cell lines.
Dawson MJ; Trapani JA
J Cell Biochem; 1995 Jan; 57(1):39-51. PubMed ID: 7536752
[TBL] [Abstract][Full Text] [Related]
12. Spectrum of biological activity of interferons.
Battistini A; Affabris E; Fiorucci G; Coccia EM; Romeo G; Marziali G; Rossi GB
Ann Ist Super Sanita; 1990; 26(3-4):227-53. PubMed ID: 1708952
[TBL] [Abstract][Full Text] [Related]
13. [Interferons. Treatment of malignant hemopathies with interferons].
Guilhot F; Sadoun A; Delwail V
Ann Med Interne (Paris); 1993; 144(8):548-56. PubMed ID: 7513980
[TBL] [Abstract][Full Text] [Related]
14. Individual and combined tumoricidal effects of dexamethasone and interferons on human leukocyte cell lines.
Pan LY; Guyre PM
Cancer Res; 1988 Feb; 48(3):567-71. PubMed ID: 3121176
[TBL] [Abstract][Full Text] [Related]
15. Synergistic antitumor effects of a combination of interferons and retinoic acid on human tumor cells in vitro and in vivo.
Lindner DJ; Borden EC; Kalvakolanu DV
Clin Cancer Res; 1997 Jun; 3(6):931-7. PubMed ID: 9815768
[TBL] [Abstract][Full Text] [Related]
16. Inborn errors of interferon (IFN)-mediated immunity in humans: insights into the respective roles of IFN-alpha/beta, IFN-gamma, and IFN-lambda in host defense.
Zhang SY; Boisson-Dupuis S; Chapgier A; Yang K; Bustamante J; Puel A; Picard C; Abel L; Jouanguy E; Casanova JL
Immunol Rev; 2008 Dec; 226():29-40. PubMed ID: 19161414
[TBL] [Abstract][Full Text] [Related]
17. Effect of recombinant human fibroblast interferon and mezerein on growth, differentiation, immune interferon binding and tumor associated antigen expression in human melanoma cells.
Fisher PB; Hermo H; Solowey WE; Dietrich MC; Edwalds GM; Weinstein IB; Langer JA; Pestka S; Giacomini P; Kusama M
Anticancer Res; 1986; 6(4):765-74. PubMed ID: 2944474
[TBL] [Abstract][Full Text] [Related]
18. Synergistic effects of IL-6 and IFN-gamma on carcinoembryonic antigen (CEA) and HLA expression by human colorectal carcinoma cells: role for endogenous IFN-beta.
Dansky-Ullmann C; Salgaller M; Adams S; Schlom J; Greiner JW
Cytokine; 1995 Feb; 7(2):118-29. PubMed ID: 7780031
[TBL] [Abstract][Full Text] [Related]
19. Potential role for retinoic acid receptor-gamma in the inhibition of breast cancer cells by selective retinoids and interferons.
Fanjul AN; Bouterfa H; Dawson M; Pfahl M
Cancer Res; 1996 Apr; 56(7):1571-7. PubMed ID: 8603404
[TBL] [Abstract][Full Text] [Related]
20. Effects of interferons alpha,beta,gamma alone or in combination on the phenotype of human colon carcinoma cells.
Brouty-Boyé D; Maunoury MT; Lowy R
Anticancer Res; 1988; 8(1):197-203. PubMed ID: 2451894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
